<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119353">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918670</url>
  </required_header>
  <id_info>
    <org_study_id>FrenchAFAblationSurvey</org_study_id>
    <nct_id>NCT01918670</nct_id>
  </id_info>
  <brief_title>A French Multi-centric Atrial Fibrillation Catheter Ablation Survey</brief_title>
  <acronym>FrenchAF</acronym>
  <official_title>A French Multi-centric Atrial Fibrillation Catheter Ablation Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinique Pasteur</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital of Grenoble, Grenoble, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nouvelle Clinique Nantaise, Nantes, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Parly 2 Medical Surgical Center (CMC), Le Chesnay, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of Rouen, Rouen, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinique Pasteur</source>
  <oversight_info>
    <authority>France: no authority.</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a
      procedure that is currently used for the treatment of symptomatic atrial fibrillation
      patients.

      We have organized a multi-centric national survey of catheter ablation of atrial
      fibrillation in order to have a feedback on the type of procedures being performed and the
      overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Atrial fibrillation relapse</measure>
    <time_frame>starting 3 months after the procedure till an average of 18months follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Early atrial fibrillation relapse</measure>
    <time_frame>first 3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <condition>Observation of Outcome After Catheter Ablation of Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Pasteur</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Grenoble</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Nantes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Parly</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Rennes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Rouen</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>catheter ablation of atrial fibrillation</intervention_name>
    <description>electric pulmonary vein disconnection</description>
    <arm_group_label>Pasteur</arm_group_label>
    <arm_group_label>Grenoble</arm_group_label>
    <arm_group_label>Nantes</arm_group_label>
    <arm_group_label>Parly</arm_group_label>
    <arm_group_label>Rennes</arm_group_label>
    <arm_group_label>Rouen</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing catheter ablation in one of the registry centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients undergoing catheter ablation of atrial fibrillation or left atrial
             flutter

        Exclusion Criteria:

          -  patients undergoing catheter ablation of other types of arrhythmia
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 6, 2013</lastchanged_date>
  <firstreceived_date>August 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinique Pasteur</investigator_affiliation>
    <investigator_full_name>Serge Boveda</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>atrial fibrillation; catheter ablation; relapse; stroke; death</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
